PenRad Technologies, Inc. software

No EMR can match the value, insight or the support we provide with our mammography information system. With a growing shortage of radiologists, technologists and IT staff, PenRad MIS offers productivity and financial gains along with many other benefits not fully recognized. This product significantly improves professional productivity, quality and revenue in mammography reporting workflow through automating tasks and eliminating duplication, secondary data input and transcription.

PenTrac is designed for facilities that are seeking a solution to improve efficiency and standardization in mammography, patient tracking and MQSA reporting. The program enhances patient care workflow by automating management of patient recalls and reminders, letter generation, statistics and MQSA reports, saving time and money. PenTrac has an easy upgrade path to the full PenRad MIS (mammography information system) for comprehensive reporting.

Lung screening presents a number of challenges for diagnostic imaging centers with Low Dose Computed Tomography (LDCT). Patients must be screened for eligibility requirements, and participating centers are required to upload pertinent exam information to a lung cancer screening registry in order to qualify for payment.

Assists and automates imaging providers that monitor resolution as part of their practice liability management and patient care, providing proactive patient result management. PenAlert is a compliment to PenRad’s PenLung for tracking, audit and administrative needs for LDCT lung screening for data submittal to ACR registry, and also compliments PenTrac and PenRad for breast imaging and procedures, each facilitating tracking, administrative and audit needs for MQSA and data submittal for NMDB. This solution also provides high value for referring physicians, reducing burden to contact patients to explain results, thus offering a differential in marketplace for imaging center.

PenRad’s PenGen system allows facilities to collect and manage patients’ risk assessments and genetic testing eligibility. System calculates real-time cancer risk scores, and Genetic testing eligibility based on multiple models, for patient and relatives.

PenFetch automatically transfers images in advance directly to workstations or PACs to eliminate staff wait-time for images to appear. PenFetch automatically processes after-hours, before patient arrives, and/or processes walk-ins immediately. Why PreFetch with PenFetch? Save time and money. When the Radiologist opens a study to read, and the relevant prior images are not available, they have to wait while the images are retrieved from the PACS to the workstation. This wastes time and network resources, thus slowing down report turnaround time. Time is also wasted in the imaging room while the Technologists wait for priors to appear for review on their imaging workstations. Many facilities spend time and money on staff to manually look-up tomorrow’s patients, and select prior images to transfer to workstations. All this and more can all be automated with PenFetch

Visualize: Vascular generates focused 3-D rendering from 2-D standard ultrasound images and effectively tracks the true lumen in arterial pathways. Visualize focuses on the lumen and residual lumen by essentially removing the other image content revealing a 3-D rendering of the active area through which the blood can flow. Visualize provides direct luminal measurements to calculate luminal reduction directly from ultrasound imaging.

Conventional markers typically consist of solid objects, that often interfere with imaging procedures and limited permanent visibility. VizMark™ is a permanent, fully-implantable, hermetically-sealed and well-visualized in all tumor and tissue types. VizMark™ produces a change in signal intensity under magnetic resonance imaging. VizMark™ is the macromolecular marker of the future, specifically designed to avoid interference when viewed under magnetic imaging. The marker produces a change in signal intensity under MRI to enable the marker to be permanently well-visualized under all tumor types and all tissue types. Of the 70+ biopsy markers on the market, VizMark™ is the only to allow for obstruction free imaging.